<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03719313</url>
  </required_header>
  <id_info>
    <org_study_id>EIG-LNF-011</org_study_id>
    <nct_id>NCT03719313</nct_id>
  </id_info>
  <brief_title>Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a</brief_title>
  <acronym>D-LIVR</acronym>
  <official_title>A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eiger BioPharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eiger BioPharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two LNF-containing regimens will be evaluated in the D-LIVR Phase 3 study: (1) LNF/RTV/PEG
      IFN-alfa-2a and (2) LNF/RTV. Each of these arms will have efficacy endpoints that measure
      clinical benefit with regard to viral suppression and alanine aminotransferase (ALT)
      normalization. For each LNF-containing regimen, a composite endpoint of EOT (48 weeks)
      virologic response and ALT normalization will be used. Virologic response will be defined as
      a 2 log10 IU/mL reduction from baseline.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This partially double-blind, randomized study will employ a matrix (factorial) design to
      evaluate the efficacy and safety of LNF 50 mg/RTV 100 mg twice per day (BID) with and without
      PEG IFN-alfa-2a 180 mcg once-weekly (QW) for 48 weeks compared to no treatment (placebo LNF
      and placebo RTV) in patients chronically infected with hepatitis delta virus (HDV) and
      receiving anti-HBV (hepatitis B virus) nucleos(t)ide maintenance therapy.

      Approximately 400 patients will be randomized with an allocation ratio of 7:5:2:2 All
      patients will receive/maintain background anti-HBV nucleos(t)ide therapy with entecavir or
      tenofovir for at least 12 weeks prior to initiating study therapy.

      All patients who complete 48 weeks of treatment will have a liver biopsy for histology
      assessment at EOT and will be followed for an additional 24 weeks off study treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the composite virologic and biochemical response rate at end-of-treatment (EOT) in patients who receive LNF 50 mg/RTV 100 mg BID vs patients who receive placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To compare the composite virologic and biochemical response rate at EOT in patients who receive LNF 50 mg/RTV 100 mg BID with PEG IFN-alfa-2a 180 mcg QW vs patients who receive placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare the histologic response rate at EOT in patients who receive LNF 50 mg/RTV 100 mg BID vs patients who receive placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To compare the histologic response rate at EOT in patients who receive LNF 50 mg/RTV 100 mg BID with PEG IFN-alfa-2a 180 mcg QW vs patients who receive placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the health-related quality of life (HRQL) over a 48-week treatment period in patients who receive LNF 50 mg/RTV 100 mg BID vs placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the HRQL over a 48-week treatment period in patients who receive LNF 50 mg/RTV 100 mg BID/PEG IFN-alfa-2a 180 mcg QW vs placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] over a 48-week treatment period in patients who receive LNF 50 mg/RTV 100 mg BID vs placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] over a 48-week treatment period in patients who receive LNF 50 mg/RTV 100 mg BID/PEG IFN-alfa-2a 180 mcg QW vs placebo.</measure>
    <time_frame>48 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Hepatitis Delta Virus</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lonafarnib 50 mg BID + Ritonavir 100 mg BID</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lonafarnib 50 mg BID + Ritonavir 100 mg BID + PEG IFN alfa-2a 180 mcg QW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>placebo Lonafarnib + placebo Ritonavir + PEG IFN-alfa-2a 180 mcg QW</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo Lonafarnib + placebo Ritonavir</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lonafarnib</intervention_name>
    <description>Lonafarnib (LNF) 50 mg BID</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>EBP994</other_name>
    <other_name>Sarasar</other_name>
    <other_name>LNF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ritonavir</intervention_name>
    <description>Ritonavir (RTV) 100 mg BID</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>Norvir</other_name>
    <other_name>RTV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PEG IFN-alfa-2a</intervention_name>
    <description>PEG IFN alfa-2a 180 mcg QW</description>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <other_name>Pegasys</other_name>
    <other_name>pegylated interferon-alfa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Lonafarnib</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Ritonavir</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Chronic HDV infection for at least 6 months in duration, documented by a positive HDV
             antibody test and HDV RNA â‰¥ 500 IU/mL.

             Note: All genotypes of HDV permitted.

          2. Demonstrable suppression of HBV DNA following at least 12 weeks of anti-HBV
             nucleos(t)ide treatment with entecavir or tenofovir prior to initiating therapy.

          3. Serum ALT &gt; 1.3 x upper limit of the normal range (ULN) and &lt; 10 x ULN.

          4. Baseline liver biopsy demonstrating evidence of chronic hepatitis.

          5. ECGs demonstrating no acute ischemia or clinically significant abnormality.

          6. Normal dilated retinal examination.

        Exclusion Criteria:

        General Exclusions

          1. Previous use of LNF within 12 months.

          2. Current or previous history of decompensated liver disease.

          3. Co-infected with human immunodeficiency virus or hepatitis C virus (HCV) by detectable
             HIV RNA and HCV RNA, respectively.

          4. Evidence of significant portal hypertension.

          5. Current evidence or history of ascites requiring diuretics or paracentesis, or hepatic
             encephalopathy.

          6. History of hepatocellular carcinoma.

          7. Patients with any of the following:

               -  Current eating disorder

               -  Evidence of alcohol substance use disorder.

               -  Drug abuse within the previous 6 months before screening.

          8. Prior history or current evidence of any of the following:

               -  Immunologically mediated disease,

               -  Retinal disorder or clinically relevant ophthalmic disorder,

               -  Any malignancy within 5 years before screening,

               -  Cardiomyopathy or significant ischemic cardiac or cerebrovascular disease,

               -  Chronic pulmonary disease,

               -  Pancreatitis or colitis,

               -  Severe or uncontrolled psychiatric disorder.

          9. Other significant medical condition that may require intervention during the study.

         10. Any condition that may impact proper absorption.

         11. Therapy with an immunomodulatory agent, IFN-Î± (eg, IFN alfa-2a or IFN-alfa-2b, or
             pegylated IFN-alfa-2a or alfa 2b), cytotoxic agent, or chronic systemic
             corticosteroids within 12 months of screening.

         12. Use of heparin or warfarin.

         13. Systemic antibiotics, antifungals, or antivirals for treatment of active infection
             other than HBV.

         14. Receipt of systemic immunosuppressive therapy.

         15. History or evidence for any intolerance or hypersensitivity to LNF, RTV, PEG
             IFN-alfa-2a, tenofovir or entecavir.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sue Speyer</last_name>
    <phone>650-272-6138</phone>
    <email>DLIVR@eigerbio.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCSF Fresno</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonia Garcia</last_name>
      <phone>559-459-6399</phone>
      <email>sgarcia@fresno.ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Marina Roytman, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruane Clinical Research Group Inc.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Reynell</last_name>
      <phone>323-954-0400</phone>
      <phone_ext>236</phone_ext>
      <email>lreynell@ruaneclinicalresearch.com</email>
    </contact>
    <contact_backup>
      <last_name>Dani Ain</last_name>
      <email>dain@ruaneclinicalresearch.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sergio Rojter, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asia Pacific Liver Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mimi Chang</last_name>
      <phone>213-207-5793</phone>
      <email>mimichang@verity.org</email>
    </contact>
    <investigator>
      <last_name>Ho Bae, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Swati Toppo</last_name>
      <phone>650-721-4326</phone>
      <email>stoppo@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Paul Kwo, Dr.</last_name>
      <email>pkwo@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Kwo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Davis Health System</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandeep Dhaliwal</last_name>
      <phone>916-734-8696</phone>
      <email>sandhaliwal@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Stuart Cohen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Medical Center Sacramento</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95825</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renee Cunanan</last_name>
      <phone>916-973-4885</phone>
      <email>renee.j.cunanan@kp.org</email>
    </contact>
    <investigator>
      <last_name>Chhaya P Hasyagar, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University Medical Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510-3206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Chau</last_name>
      <phone>203-785-3409</phone>
      <email>hong.chau@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Lim, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Schiff Center for Liver Disease</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katheryn Dae</last_name>
      <phone>305-243-1104</phone>
      <email>kqd1@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Eugene Schiff, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Goldman</last_name>
      <phone>312-563-3919</phone>
      <email>Diana_Goldman@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy Reau, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals &amp; Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Valestin</last_name>
      <phone>319-353-4574</phone>
      <email>jessica-valestin@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Arvind Murali, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Institutes of Health</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patient Coordinator</last_name>
      <phone>301-435-6121</phone>
    </contact>
    <investigator>
      <last_name>Christopher Koh, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Tallon</last_name>
      <phone>313-916-2684</phone>
      <email>etallon2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Stuart Gordon, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Lewis</last_name>
      <phone>212-824-7931</phone>
      <email>meredith.lewis@mssm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shanti Mangar</last_name>
      <phone>212-824-7587</phone>
      <email>shanti.mangar@mssm.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Douglas Dieterich, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Olson</last_name>
      <phone>646-962-4926</phone>
      <email>Mary.Olson@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Viviana Figueroa-Diaz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea DiBella</last_name>
      <phone>585-275-0803</phone>
      <email>chelsea_dibella@urmc.rochester.edu</email>
    </contact>
    <investigator>
      <last_name>Jonathan Huang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Sooner Research</name>
      <address>
        <city>Norman</city>
        <state>Oklahoma</state>
        <zip>73071</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kurt Smith</last_name>
      <phone>405-329-0474</phone>
      <email>ksmith@centralsooner.com</email>
    </contact>
    <investigator>
      <last_name>Robert Gordon, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-8857</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Rowan</last_name>
      <phone>214-645-6126</phone>
      <email>debra.rowan@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>William Lee, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jignesh Patel</last_name>
      <phone>713-798-1966</phone>
      <email>jignesh.patel@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>John Vierling, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZNA Stuivenberg</name>
      <address>
        <city>Antwerpen</city>
        <zip>2060</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristof Lesneuck</last_name>
      <phone>+32498648167</phone>
      <email>kristof.lesneuck@sgs.com</email>
    </contact>
    <investigator>
      <last_name>Bourgeois, Stefan Bourgeois, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>C.H.U. Brugmann</name>
      <address>
        <city>Bruxelles</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DaphnÃ© Benteyn</last_name>
      <phone>+3224773621</phone>
      <email>adeline.derodezbenavent@chu-brugmann.be</email>
    </contact>
    <investigator>
      <last_name>Luc Lasser, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires de Bruxelles Hopital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nesrine Amari</last_name>
      <phone>+32498648167</phone>
      <email>kristof.lesneuck@sgs.com</email>
    </contact>
    <investigator>
      <last_name>Christophe Moreno, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Muylle</last_name>
      <phone>+3238213633</phone>
      <email>hannah.muylle@uza.be</email>
    </contact>
    <investigator>
      <last_name>Thomas Vanwolleghem, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Sart Tilman</name>
      <address>
        <city>LiÃ¨ge</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Wertz</last_name>
      <phone>+3242844495</phone>
      <email>swertz@chuliege.be</email>
    </contact>
    <investigator>
      <last_name>Jean Delwaide, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Acibadem City Clinic Tokuda Hospital Ead</name>
      <address>
        <city>Sofia</city>
        <zip>1407</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marieta Gamzova-Kelleva</last_name>
      <phone>(359) 884-9331 x98</phone>
      <email>marieta.gamzova@acibademcityclinic.bg</email>
    </contact>
    <investigator>
      <last_name>Rozalina Balabanska, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Alexandrovska&quot; EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nataliya Kolarova</last_name>
      <phone>+359 892 226 039</phone>
      <email>n.kolarova@rdservices.org</email>
    </contact>
    <investigator>
      <last_name>Diana Stefanova-Petrova, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMHAT &quot;Sv. Ivan Rilski&quot;, EAD</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Petkova</last_name>
      <phone>359882401434</phone>
      <email>mdpetkovamd@abv.bg</email>
    </contact>
    <investigator>
      <last_name>Krassimir Antonov, AProf.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Center &quot;Nov Rehabilitatsionen Tsentar&quot;, EOOD</name>
      <address>
        <city>Stara Zagora</city>
        <zip>6000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Radicheva</last_name>
      <phone>359887095903</phone>
      <email>d_radicheva@abv.bg</email>
    </contact>
    <investigator>
      <last_name>Mariana Penkova, AProf.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Kilvert</last_name>
      <phone>403-220-8966</phone>
      <email>lvkilver@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Matt Sadler, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seham Noureldin</last_name>
      <phone>(416) 340-4800</phone>
      <phone_ext>8681</phone_ext>
      <email>Seham.Noureldin@uhnresearch.ca</email>
    </contact>
    <investigator>
      <last_name>Jordan Feld, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto Liver Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M6H 3M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marzena Magnes</last_name>
      <phone>416-652-2512</phone>
      <email>magnes.marzena8@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Magdy Elkhashab, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre/Glen Site / Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Roger</last_name>
      <phone>(514) 934-1934</phone>
      <phone_ext>32547</phone_ext>
      <email>jonathan.roger@muhc.mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Marc Deschenes, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nice - HÃ´pital de l'Archet 2</name>
      <address>
        <city>Nice Cedex 3</city>
        <state>Alpes Maritimes</state>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle Mouraux</last_name>
      <phone>+33492039406</phone>
      <email>mouraux.e@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Albert Tran, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg - HÃ´pital Hautepierre</name>
      <address>
        <city>Strasbourg Cedex</city>
        <state>Bas Rhin</state>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline Simo-Noubissie</last_name>
      <phone>+33369549682</phone>
      <email>pauline.simo-noumbissie@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>FranÃ§ois Habersetzer, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux - HÃ´pital Haut-LÃ©vÃªque</name>
      <address>
        <city>Pessac</city>
        <state>Gironde</state>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Emmanuel Truchot</last_name>
      <phone>+33557656439</phone>
      <email>paul-emmanuel.truchot@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Victor De Ledinghen, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Beaujon</name>
      <address>
        <city>Clichy cedex</city>
        <state>Hauts De Seine</state>
        <zip>92110</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Narguet</last_name>
      <phone>+33140875514</phone>
      <email>stephanie.narguet@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick Marcellin, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble - HÃ´pital Nord</name>
      <address>
        <city>La Tronche</city>
        <state>Isere</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Audoin</last_name>
      <phone>+33668082241</phone>
      <email>paudoin@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Marie-NoÃ«lle Hilleret, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de la Croix Rousse</name>
      <address>
        <city>Lyon</city>
        <state>Rhone</state>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benedicte Poumaroux</last_name>
      <phone>33426732737</phone>
      <email>benedicte.poumaroux@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Fabien Zoulim, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Jean Verdier</name>
      <address>
        <city>Bondy</city>
        <state>Seine Saint Denis</state>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Severine Brule-Donneger</last_name>
      <email>severine.donneger@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Nathalie Ganne, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Paul Brousse</name>
      <address>
        <city>Villejuif</city>
        <state>Val De Marne</state>
        <zip>94804</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Tresson</last_name>
      <phone>+33145593028</phone>
      <email>sylvie.tresson-ext@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Didier Samuel, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden Wuerttemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giusi Teufel</last_name>
      <phone>0761/270-32613</phone>
      <email>giusi.teufel@uniklinik-freiburg.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Neumann-Haefelin, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <state>Baden Wuerttemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Klag</last_name>
      <phone>49707184457</phone>
      <email>thomas.klag@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Berg, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Goethe UniversitÃ¤t Frankfurt Am Main</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathrin Sprinzl</last_name>
      <phone>4969630187687</phone>
      <email>kathrin.sprinzl@kgu.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Zeuzem, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Hinneburg</last_name>
      <phone>495115325702</phone>
      <email>hinneburg.linda@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Heiner Wedemeyer, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein Westfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandra Christoph</last_name>
      <phone>0201-723 4410</phone>
      <email>sandra.christoph@uk-essen.de</email>
    </contact>
    <investigator>
      <last_name>Gudrun Martina Hilgard, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zentrum fÃ¼r Infektiologie Berlin Prenzlauer Berg GmbH</name>
      <address>
        <city>Berlin</city>
        <zip>10439</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Gersbacher-Runge</last_name>
      <phone>+49 30-948729-41</phone>
      <email>gersbacher-runge@zibp.de</email>
    </contact>
    <investigator>
      <last_name>Patrick Ingiliz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite - Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Markus ReiÃŸ</last_name>
      <phone>49 30 450 66 53 18</phone>
      <email>markus.reiss@charite.de</email>
    </contact>
    <investigator>
      <last_name>Tobias Mueller, AProf.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kirsten Aue-Raschka</last_name>
      <email>k.aue-raschka@uke.de</email>
    </contact>
    <contact_backup>
      <email>j.schulze-zur-wiesch@uke.de</email>
    </contact_backup>
    <investigator>
      <last_name>Julian Schulze zur Wiesch, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens Laiko</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofia Anagnostopoulou</last_name>
      <phone>302132061166</phone>
      <email>sopanagn@gmail.com</email>
    </contact>
    <investigator>
      <last_name>George Papatheodoridis, AProf.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HaEmek Medical Center</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenia Sharav</last_name>
      <phone>+97226555467</phone>
      <email>genia_sh@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Rawi Hazzan, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soroka University Medical Center</name>
      <address>
        <city>Beer-Sheva</city>
        <zip>84001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irena Kantor</last_name>
      <phone>+972528838849</phone>
      <email>kantorir@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Ohad Etzion, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rambam Health Care Center</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vered Ben-Hakoun</last_name>
      <phone>+97248542017</phone>
      <email>v_ben-hakoon@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Ella Veitsman, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Lady Davis Carmel Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>34362</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orly Azulay</last_name>
      <phone>97248250499</phone>
      <email>orlyaz@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Eli Zuckerman, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Armoni</last_name>
      <phone>+97226555467</phone>
      <email>danielarmoni@szmc.org.il</email>
    </contact>
    <investigator>
      <last_name>Yoav Lurie, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hadassah University Hospital - Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yasmin Malabi</last_name>
      <phone>(972) 526-3522 x87</phone>
      <email>yasminm@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Rifaat Safadi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Galilee Medical Center</name>
      <address>
        <city>Nahariya</city>
        <zip>2210001</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelly Bar Guy</last_name>
      <phone>+97249107748</phone>
      <email>nellyb@gmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Nimer, Assy Nimer, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52363</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avishag Hassid</last_name>
      <phone>+97235307002</phone>
      <email>avishag.hassid@sheba.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Ziv Ben Ari, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale Casa Sollievo della Sofferenza</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <state>Foggia</state>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rossana Fontana</last_name>
      <phone>390882410785</phone>
      <email>fontana_r13@yahoo.it</email>
    </contact>
    <investigator>
      <last_name>Grazia Niro, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Rozzano</city>
        <state>Milano</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rossella Meli</last_name>
      <phone>+39 3914515901</phone>
      <email>rossella.meli@humanitas.it</email>
    </contact>
    <investigator>
      <last_name>Alessio Aghemo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serena Zaltron</last_name>
      <email>francesco.castelli@unibs.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Castelli, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia</name>
      <address>
        <city>Foggia</city>
        <zip>71100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Di Stefano</last_name>
      <email>aledisti90@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Teresa Antonia Santantonio, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico G. Martino</name>
      <address>
        <city>Messina</city>
        <zip>98124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaia Caccamo</last_name>
      <phone>390902212000</phone>
      <email>gcaccamo@unime.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Raimondo, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Borghi</last_name>
      <phone>+390250320378</phone>
      <email>marta-borghi@libero.it</email>
    </contact>
    <investigator>
      <last_name>Pietro Lampertico, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda)</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Vassalli</last_name>
      <phone>+390264442189</phone>
      <email>sara.vassalli@ospedaleniguarda.it</email>
    </contact>
    <investigator>
      <last_name>Massimo Puoti, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universita di Modena e Reggio Emilia. Nuovo Ospedale civil</name>
      <address>
        <city>Modena</city>
        <zip>1355</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marzia Margotti</last_name>
      <phone>+39 (59) 396-2209</phone>
      <email>marzia.margotti@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Francesca Carubbi, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria &quot;Federico II&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppina Brancaccio</last_name>
      <phone>393383738725</phone>
      <email>ggbrancaccio@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Giovanbattista Gaeta, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria di Parma</name>
      <address>
        <city>Parma</city>
        <zip>43100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diletta Laccabue</last_name>
      <phone>+390521702727</phone>
      <email>dilettal@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Carlo Ferrari, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Romana Guarino</last_name>
      <phone>+39 050996709</phone>
      <email>francesca.guarino.frg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maurizia Rossana Brunetto, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Policlinico Tor Vergata</name>
      <address>
        <city>Roma</city>
        <zip>00133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Milana</last_name>
      <phone>390672596803</phone>
      <email>martinamilana@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ilaria Lenci, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera CittÃ  della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giulia Verzon</last_name>
      <phone>+39 011 6336224</phone>
      <email>verzongiulia@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Alessia Ciancio, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ISMP Spitalul Clinic Republican &quot;Timofei Mosneaga&quot;</name>
      <address>
        <city>Chisinau</city>
        <zip>2025</zip>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugen Tcaciuc</last_name>
      <phone>373744649400</phone>
      <email>eugen.tcaciuc@usnf.md</email>
    </contact>
    <investigator>
      <last_name>Adela Turcanu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rtl Sm Srl</name>
      <address>
        <city>Chisinau</city>
        <zip>MD-2025</zip>
        <country>Moldova, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Raileanu</last_name>
      <phone>37369104768</phone>
      <email>raidiana29@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Victoria Babitchi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Liver Center</name>
      <address>
        <city>Ulaanbaatar</city>
        <zip>14230-0054</zip>
        <country>Mongolia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Delgersaikhan Zulkhuu</last_name>
      <email>z.delgersaikhan@onomfoundation.org</email>
    </contact>
    <investigator>
      <last_name>Naranjargal Dashdorj, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Grafton</city>
        <zip>1023</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faye Manu</last_name>
      <phone>64 9 307 4949</phone>
      <email>Fayem@adhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Edward Gane, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Aga Khan University</name>
      <address>
        <city>Karachi</city>
        <zip>74800</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paras Shahzad</last_name>
      <phone>+92 332 6932696</phone>
      <email>paras.shahzad@aku.edu</email>
    </contact>
    <investigator>
      <last_name>Saeed Hamid, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.C MedLife S.A</name>
      <address>
        <city>Bucuresti</city>
        <zip>010719</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oana Marin</last_name>
      <phone>+40758110071</phone>
      <email>oana.marin@scala-cr.com</email>
    </contact>
    <investigator>
      <last_name>Ion-Eugeniu Craciun, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Universitar de Urgenta Militar Central &quot;Dr. Carol Davila&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>010825</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Balaban</last_name>
      <phone>40742519793</phone>
      <email>vbalaban@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Mariana Jinga, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul National de Boli Infectioase &quot;Prof. Dr. Matei Bals&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>021105</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anca Streinu-Cercel</last_name>
      <phone>40722998425</phone>
      <email>anca_sc@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Adrian Streinu-Cercel, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul National de Boli Infectioase &quot;Prof. Dr. Matei Bals&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>021105</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Radu</last_name>
      <phone>40722597702</phone>
      <email>drmnradu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Florin Caruntu, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul Clinic Fundeni</name>
      <address>
        <city>Bucuresti</city>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Iliescu</last_name>
      <phone>40722235695</phone>
      <email>laura_ate@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>George Stancu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul Clinic Fundeni</name>
      <address>
        <city>Bucuresti</city>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Liliana Simona Gheorghe, AProf.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundatia &quot;Dr. Victor Babes&quot;</name>
      <address>
        <city>Bucuresti</city>
        <zip>030303</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madalina Neata</last_name>
      <phone>+40746097986</phone>
      <email>mada_becheru@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>George Sebastian Gherlan, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta Cluj Napoca</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400006</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Liliana</last_name>
      <phone>(407) 422-0496 x3</phone>
      <email>lilidavid2007@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Dan Lucian Dumitrascu, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nieves Palomo</last_name>
      <phone>+34932746000EXT6562</phone>
      <email>mnieves.merchan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Buti Ferret, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Viton</last_name>
      <phone>+34912071876</phone>
      <email>laura.ucicec@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Javier Garcia Samaniego Rey, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari i Politecnic La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Almudena Cubells Garcia</last_name>
      <phone>+34961244000</phone>
      <email>almudena_cubells@iislafe.es</email>
    </contact>
    <investigator>
      <last_name>Maria Garcia Eliz, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Falu Lasarett</name>
      <address>
        <city>Falun</city>
        <zip>79182</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessika Wikblom</last_name>
      <phone>4623492971</phone>
      <email>jessica.wikblom@regiondalarna.se</email>
    </contact>
    <investigator>
      <last_name>Anna-Karin Jonsson, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska Universitetssjukhuset Huddinge</name>
      <address>
        <city>Huddinge</city>
        <zip>14157</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Cederberg</last_name>
      <phone>+46 8 585 813 58</phone>
      <email>susanne.cederberg@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Soo Aleman, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SkÃ¥nes Universitetssjukhus</name>
      <address>
        <city>MalmÃ¶</city>
        <zip>205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Qvist</last_name>
      <phone>+4646175334</phone>
      <email>louise.qvist@med.lu.se</email>
    </contact>
    <investigator>
      <last_name>Leo Flamholc, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern, Hepatologie, Bauchzentrum, INO- A, Ms. Kathrin Husi</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathrin Husi</last_name>
      <phone>+41316325933</phone>
      <email>kathrin.husi@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Nasser Semmo, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Changhua Christian Hospital</name>
      <address>
        <city>Changhua</city>
        <zip>50004</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ning-Ying Chiang</last_name>
      <phone>+88647238595 x3245</phone>
      <email>jenny.chiang@ttmcsmo.com</email>
    </contact>
    <investigator>
      <last_name>Wei-Wen Su, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chia-Yi Christian Hospital</name>
      <address>
        <city>Chia-Yi City</city>
        <zip>600</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chia-Yi Chen</last_name>
      <phone>(886) 527-6504 xext2535</phone>
      <email>cych12497@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chi-Yi Chen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hsin-Ting Chuang</last_name>
      <phone>+88673121101 x6770</phone>
      <email>shinkansen0301@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Wan-Long Chuang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>824</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiu-Jung Chen</last_name>
      <phone>+88677317123 x2446</phone>
      <email>cjc2446@yahoo.com.tw</email>
    </contact>
    <investigator>
      <last_name>Tsung-Hui Hu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chia Chi Chien</last_name>
      <phone>+886228712121 x3219</phone>
      <email>jenice.chien@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chien-Wei Su, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital, Linkou</name>
      <address>
        <city>Taoyuan County</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi-Meng Chiang</last_name>
      <phone>+88633281200 x2222</phone>
      <email>bluejiang1976@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yi-Cheng Chen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dicle University, Medical Faculty</name>
      <address>
        <city>Diyarbakir</city>
        <zip>21280</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Necla Aytekin</last_name>
      <phone>5061377855</phone>
      <email>necla.aytekin@medismart.com.tr</email>
    </contact>
    <investigator>
      <last_name>Mustafa Kemal Celen, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Koc University Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ozgun Gokmen</last_name>
      <phone>905498231577</phone>
      <email>ogokmen@kuh.ku.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Cihan Yurhadin, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ege University Medical Faculty</name>
      <address>
        <city>Izmir</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aysegul Kozak</last_name>
      <phone>+905066318382</phone>
      <email>aysegul.kozak@medex-smo.com</email>
    </contact>
    <investigator>
      <last_name>Ulus Akarca, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Payaniandy</last_name>
      <phone>+442034165000</phone>
      <email>louise.payaniandy2@bartshealth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Patrick Kennedy, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gartnavel General Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Strathclyde</state>
        <zip>G12 0YN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Ocker</last_name>
      <phone>+441412113261</phone>
      <email>kate.ocker@ggc.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Erica Peters, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Moldova, Republic of</country>
    <country>Mongolia</country>
    <country>New Zealand</country>
    <country>Pakistan</country>
    <country>Romania</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Vietnam</country>
  </removed_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 18, 2018</study_first_submitted>
  <study_first_submitted_qc>October 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis D</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Ritonavir</mesh_term>
    <mesh_term>Interferon-alpha</mesh_term>
    <mesh_term>Peginterferon alfa-2a</mesh_term>
    <mesh_term>Interferon alpha-2</mesh_term>
    <mesh_term>Lonafarnib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

